Bayer Diabetes Care has a long history of innovation and commitment to research in diabetes. Here, you will find links to our research publications and other medical content. Navigate to the section that interests you using the Table of Contents to the right, or scroll through them all for a more complete look at Bayer’s clinical studies and research.
Miscoding and Other User Errors: Importance of Ongoing Education for Proper Blood Glucose Monitoring Procedures
Schrock, L. Jour Diab Sci Tech 2008; 2(4):563-567.
Objective: This article reviews the literature and reports on a study that documented the frequency of manual code-requiring blood glucose (BG) meters that were miscoded at the time of the patient's initial appointment in a hospital-based outpatient diabetes education program.
Conclusion: These findings underscore the importance of checking the patient's BG meter code (if required) and procedure for testing BG at each encounter with a healthcare professional or providing the patient with a meter that does not require manual entry of a code number or chip to match the container of test strips (i.e., an autocode meter.)
Note: Bayer’s CONTOUR® USB meter has No Coding™ technology.
Predicted Blood Glucose from Insulin Administration Based on Values from Miscoded Glucose Meters
Raine, CH et al. Jour Diab Sci Tech 2008; 2(4):557-562.
Objective: The proper use of many types of self-monitored blood glucose (SMBG) meters requires calibration to match strip code. Studies have demonstrated the occurrence and impact on insulin dose of coding errors with SMBG meters. This paper reflects additional analyses performed on data from Raine et al. published in 2007. It attempts to relate potential insulin dose errors to possible adverse blood glucose outcomes when glucose meters are miscoded.
Conclusion: Improperly coded blood glucose meters present potential for insulin dose errors and resultant clinically significant hypoglycemia or hyperglycemia. Patients should be instructed and periodically reinstructed in the proper use of blood glucose meters, particularly for meters that require coding.
Significant Insulin Dose Errors May Occur if Blood Glucose Results are Obtained from Miscoded Meters
Raine, Charles CH et al. Jour Diab Sci Tech 2007; 1(2):205-10.
Objective: The objective of this study was to determine inaccuracies of miscoded blood glucose (BG) meters and potential errors in insulin dose based on the values from these meters.
Conclusion: Blood glucose meter coding errors may result in significant insulin dose errors. To avoid errors, patients should be instructed to code their meters correctly or be advised to use an autocoded meter that showed superior performance over manually coded meters in this study.
Ascensia™ WinGLUCOFACTS™ Professional Software Improves Diabetes Health Outcomes
Janssen, M et al. Jour Diab Sci Tech 2007; 1(1):47-53.
Objective: This study was conducted to investigate whether use of WinGLUCOFACTS™ would improve blood glucose control, diabetes related behaviours, and patient knowledge and attitudes. The cost effectiveness of this software in a primary care setting was also studied.
Conclusion: The use of WinGLUCOFACTS™ Professional Software from Bayer HealthCare helped in the management of patients' diabetes. It improved overall glycemic control, increased their knowledge of diabetes, increased SMBG frequency, and their satisfaction with care, and was cost effective. The primary care physicians confirmed the benefit afforded by this software in the real-world management of diabetes.
Self Blood Glucose Monitoring in the Non-insulin-requiring Diabetic Patient—To Test or Not to Test
Raine, Charles CH. US Endocrine 2007: 46-48.
In this report, Dr. Raine comments on the importance of self-blood glucose monitoring in patients with type 2 diabetes. He states that therapeutic approaches must be progressive. SMBG is the singular, immediate, accurate measure available to the patient allowing therapy adjustment. With appropriate education, the patient and HCP alike can find value in testing for this patient population.
The Accuracy and Interferences in Self-Monitoring of Blood Glucose
Bode, B. US Endocrine 2007: 46-48.
This report summarizes the importance of technique and technology in blood glucose monitoring. It addresses sources of interference, such as maltose and galactose, as well as oxygen, paracetamol, uric acid, bilirubin and hematocrit. Dr. Bode concludes that when selecting the optimal glucose meter, one must consider the individual patient needs, but also the ability of the glucose monitoring system to ensure minimum risk of interference.